NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1265609580 MD
Verify on CMS → Suneeta Pinnamaneni, MD
Medical Oncology Physician in Leesburg, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 230 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
46%
generic claims · 54% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$1.6K
51 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Suneeta Pinnamaneni, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,824 Medicare Part D claims in 2023.
- 75/100
- CMS neutral score · not measured
- 2K
- Part D claims, 2023
- 46%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1265609580 · Medical Oncology Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1265609580
- ENUM-MID 2008
- TAX-NARROW 3,815
- MIPS-NEUTRAL 75/100
- RX-MID 1,824
- BOOK-THIN 282 in Florida
- PHOTO-ENUM Manik Amin · 2008
Suneeta Pinnamaneni, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,824 ≥ 83rd percentile 83% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Suneeta Pinnamaneni, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Suneeta Pinnamaneni, MD?
CMS neutral score, not measuredPrimary specialty
Medical Oncology Physician
Medicare Part D claims
1,824 165% vs specialty avg
MIPS final score
75/100
Specialty distribution in Florida
How Medical Oncology Physician compares to other specialties among Florida providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1265609580 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 05/15/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Hospital and facility affiliations
Facilities where Suneeta Pinnamaneni, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Pain And Spine Centers OF Florida LLC
Leesburg, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Suneeta Pinnamaneni, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.6K
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Suneeta Pinnamaneni, MD. To verify Suneeta Pinnamaneni, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Suneeta Pinnamaneni, MD - brand share 54.0%
Medical Oncology Physician average
54% brand-name claims vs 46% generic, on 1,824 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,824
Total Claims
$8.6M
Total Drug Cost
230
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,415
- Total Day Supply
- 64,336
- Brand vs Generic
- 54% brand / 46% generic
- Brand Drug Cost
- $8.5M
- Generic Drug Cost
- $158K
- Antibiotic Claims
- 42
Patient Demographics
- Average Patient Age
- 74.6 years
- Avg HCC Risk Score
- 2.74
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 24, 65-74: 80, 75-84: 100, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Suneeta Pinnamaneni, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Letrozole
Letrozole
119 claims
- Retacrit
Retacrit
100 claims
- Keytruda
Keytruda
95 claims
- Ondansetron Hcl
Ondansetron Hcl
77 claims
- Dexamethasone
Dexamethasone
71 claims
- Carboplatin
Carboplatin
69 claims
- Imbruvica
Imbruvica
63 claims
- Xgeva
Xgeva
58 claims
| Drug | Claims |
|---|---|
| Letrozole | 119 |
| Retacrit Epoetin Alfa-Epbx | 100 |
| Keytruda Pembrolizumab | 95 |
| Ondansetron Hcl | 77 |
| Dexamethasone | 71 |
| Carboplatin | 69 |
| Imbruvica Ibrutinib | 63 |
| Xgeva Denosumab | 58 |
| Eliquis Apixaban | 55 |
| Verzenio Abemaciclib | 45 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Suneeta Pinnamaneni, MD fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Suneeta Pinnamaneni, MD's 1,824 claims are above the specialty average of 689.
Nationwide Medical Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Pinnamaneni, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Medical Oncology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Pinnamaneni.
One of 282 Medical Oncology Physician providers enrolled in Florida, 5 are shown here.
Dr. Guillermo Abesada-Terk
M.D.
Stuart, FL
Dr. Patrick Acevedo
M.D.
Ocala, FL
Dr. Howard Adler
M.D.
Delray Beach, FL
Dr. Syed Ahmed
M.D.
Sebring, FL
Dr. Olufunke Akinbobuyi
M.D.
Hollywood, FL
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Suneeta Pinnamaneni, MD's specialty? ▼
Suneeta Pinnamaneni, MD specializes in Medical Oncology Physician and practices in Leesburg, Florida. Credentials: MD.
How much does Suneeta Pinnamaneni, MD prescribe under Medicare Part D? ▼
In 2023, Suneeta Pinnamaneni, MD wrote 1,824 Medicare Part D claims totaling $8.6M in drug costs for 230 beneficiaries.
What is Suneeta Pinnamaneni, MD's Medicare quality score? ▼
Suneeta Pinnamaneni, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Suneeta Pinnamaneni, MD located? ▼
Suneeta Pinnamaneni, MD is located at 9832 US HIGHWAY 441, Leesburg, FL, 34788. Phone: (352) 787-3341.
What is Suneeta Pinnamaneni, MD's NPI number? ▼
Suneeta Pinnamaneni, MD's National Provider Identifier (NPI) is 1265609580, issued on 05/15/2008.
Does Suneeta Pinnamaneni, MD prescribe more brand-name or generic drugs? ▼
Suneeta Pinnamaneni, MD's prescribing is 54% brand-name and 46% generic drugs by claim count, with $8.5M in brand drug costs.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Suneeta Pinnamaneni, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Suneeta Pinnamaneni, MD's most frequently prescribed drugs include Letrozole, Retacrit, Keytruda. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Suneeta Pinnamaneni, MD accept Medicare? ▼
Suneeta Pinnamaneni, MD appears in CMS Medicare data with 1,824 Part D claims and 230 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Suneeta Pinnamaneni, MD's credentials? ▼
Suneeta Pinnamaneni, MD's NPI is 1265609580 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.